Annual EPS
-$1.95
-$1.07-121.59%
31 December 2023
Summary:
NovoCure Limited annual earnings per share is currently -$1.95, with the most recent change of -$1.07 (-121.59%) on 31 December 2023. During the last 3 years, it has fallen by -$2.13 (-1183.33%). NVCR annual EPS is now -1183.33% below its all-time high of $0.18, reached on 31 December 2020.NVCR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.28
+$0.03+9.68%
30 September 2024
Summary:
NovoCure Limited quarterly earnings per share is currently -$0.28, with the most recent change of +$0.03 (+9.68%) on 30 September 2024. Over the past year, it has increased by +$0.18 (+39.13%). NVCR quarterly EPS is now -411.11% below its all-time high of $0.09, reached on 30 September 2020.NVCR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$1.40
+$0.18+11.39%
30 September 2024
Summary:
NovoCure Limited TTM earnings per share is currently -$1.40, with the most recent change of +$0.18 (+11.39%) on 30 September 2024. Over the past year, it has increased by +$0.46 (+24.73%). NVCR TTM EPS is now -836.84% below its all-time high of $0.19, reached on 30 September 2020.NVCR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -121.6% | +39.1% | +24.7% |
| 3 y3 years | -1183.3% | -115.4% | -418.5% |
| 5 y5 years | -182.6% | -1500.0% | -382.8% |
NVCR EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1183.3% | at low | -600.0% | +48.1% | -418.5% | +28.2% |
| 5 y | 5 years | -1183.3% | at low | -411.1% | +48.1% | -836.8% | +28.2% |
| alltime | all time | -1183.3% | +46.9% | -411.1% | +48.1% | -836.8% | +28.2% |
NovoCure Limited EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.28(-9.7%) | -$1.40(-11.4%) |
| June 2024 | - | -$0.31(-13.9%) | -$1.58(-12.7%) |
| Mar 2024 | - | -$0.36(-20.0%) | -$1.81(-7.2%) |
| Dec 2023 | -$1.95(+121.6%) | -$0.45(-2.2%) | -$1.95(+4.8%) |
| Sept 2023 | - | -$0.46(-14.8%) | -$1.86(+12.7%) |
| June 2023 | - | -$0.54(+8.0%) | -$1.65(+23.1%) |
| Mar 2023 | - | -$0.50(+38.9%) | -$1.34(+52.3%) |
| Dec 2022 | -$0.88(+57.1%) | -$0.36(+44.0%) | -$0.88(+14.3%) |
| Sept 2022 | - | -$0.25(+8.7%) | -$0.77(+18.5%) |
| June 2022 | - | -$0.23(+475.0%) | -$0.65(+16.1%) |
| Mar 2022 | - | -$0.04(-84.0%) | -$0.56(0.0%) |
| Dec 2021 | -$0.56(-411.1%) | -$0.25(+92.3%) | -$0.56(+107.4%) |
| Sept 2021 | - | -$0.13(-7.1%) | -$0.27(+440.0%) |
| June 2021 | - | -$0.14(+250.0%) | -$0.05(-145.5%) |
| Mar 2021 | - | -$0.04(-200.0%) | $0.11(-42.1%) |
| Dec 2020 | $0.18(-357.1%) | $0.04(-55.6%) | $0.19(0.0%) |
| Sept 2020 | - | $0.09(+350.0%) | $0.19(+58.3%) |
| June 2020 | - | $0.02(-50.0%) | $0.12(+33.3%) |
| Mar 2020 | - | $0.04(0.0%) | $0.09(-212.5%) |
| Dec 2019 | -$0.07 | $0.04(+100.0%) | -$0.08(-72.4%) |
| Sept 2019 | - | $0.02(-300.0%) | -$0.29(-34.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$0.01(-92.3%) | -$0.44(-26.7%) |
| Mar 2019 | - | -$0.13(-23.5%) | -$0.60(-14.3%) |
| Dec 2018 | -$0.69(-1.4%) | -$0.17(+30.8%) | -$0.70(+7.7%) |
| Sept 2018 | - | -$0.13(-23.5%) | -$0.65(0.0%) |
| June 2018 | - | -$0.17(-26.1%) | -$0.65(-9.7%) |
| Mar 2018 | - | -$0.23(+91.7%) | -$0.72(+2.9%) |
| Dec 2017 | -$0.70(-54.5%) | -$0.12(-7.7%) | -$0.70(-16.7%) |
| Sept 2017 | - | -$0.13(-45.8%) | -$0.84(-23.6%) |
| June 2017 | - | -$0.24(+14.3%) | -$1.10(-17.9%) |
| Mar 2017 | - | -$0.21(-19.2%) | -$1.34(-13.5%) |
| Dec 2016 | -$1.54(-58.0%) | -$0.26(-33.3%) | -$1.55(-7.9%) |
| Sept 2016 | - | -$0.39(-18.8%) | -$1.68(+4.7%) |
| June 2016 | - | -$0.48(+14.3%) | -$1.61(+8.4%) |
| Mar 2016 | - | -$0.42(+6.9%) | -$1.48(+7.0%) |
| Dec 2015 | -$3.67(+228.1%) | -$0.39(+24.8%) | -$1.39(+5.7%) |
| Sept 2015 | - | -$0.31(-11.3%) | -$1.31(+4.9%) |
| June 2015 | - | -$0.36(+10.1%) | -$1.25(+39.7%) |
| Mar 2015 | - | -$0.32(+1.5%) | -$0.89(+56.4%) |
| Dec 2014 | -$1.12(+4.3%) | -$0.32(+25.1%) | -$0.57(+125.1%) |
| Sept 2014 | - | -$0.25 | -$0.25 |
| Dec 2013 | -$1.07 | - | - |
FAQ
- What is NovoCure Limited annual earnings per share?
- What is the all time high annual EPS for NovoCure Limited?
- What is NovoCure Limited annual EPS year-on-year change?
- What is NovoCure Limited quarterly earnings per share?
- What is the all time high quarterly EPS for NovoCure Limited?
- What is NovoCure Limited quarterly EPS year-on-year change?
- What is NovoCure Limited TTM earnings per share?
- What is the all time high TTM EPS for NovoCure Limited?
- What is NovoCure Limited TTM EPS year-on-year change?
What is NovoCure Limited annual earnings per share?
The current annual EPS of NVCR is -$1.95
What is the all time high annual EPS for NovoCure Limited?
NovoCure Limited all-time high annual earnings per share is $0.18
What is NovoCure Limited annual EPS year-on-year change?
Over the past year, NVCR annual earnings per share has changed by -$1.07 (-121.59%)
What is NovoCure Limited quarterly earnings per share?
The current quarterly EPS of NVCR is -$0.28
What is the all time high quarterly EPS for NovoCure Limited?
NovoCure Limited all-time high quarterly earnings per share is $0.09
What is NovoCure Limited quarterly EPS year-on-year change?
Over the past year, NVCR quarterly earnings per share has changed by +$0.18 (+39.13%)
What is NovoCure Limited TTM earnings per share?
The current TTM EPS of NVCR is -$1.40
What is the all time high TTM EPS for NovoCure Limited?
NovoCure Limited all-time high TTM earnings per share is $0.19
What is NovoCure Limited TTM EPS year-on-year change?
Over the past year, NVCR TTM earnings per share has changed by +$0.46 (+24.73%)